-
Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Tuesday, July 9, 2024 - 12:26pm | 454Read More...Tempus AI Inc (NASDAQ:TEM) announced last week it was granted advanced diagnostic laboratory test status for its next-generation sequencing assay. These analysts provide their initial takeaways from the stock. BofA Securities On Tempus Analyst Michael Ryskin initiated coverage with a Buy rating and...
-
SolarEdge Technologies' Shares Are Trading At 5-Year Lows: Analyst Expects 'Return To Profitability' In 2025
Monday, July 8, 2024 - 11:37am | 353Read More...Shares of SolarEdge Technologies Inc (NASDAQ:SEDG) spiked in early trading on Monday, after plummeting over the past month on the company's announcement of a $300 million private offering. The stock is trading at five-year lows, following the second-quarter guidance miss, underperforming Enphase...



